Zhongshan Shijiayuan Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Zhongshan Shijiayuan Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include STRAPHENSE. The owner is based in Guangdong province.

Room 1401, Building 2, Huiya Garden, No. 5,

Huizhan East Road, Torch Development Zone, Zhongshan City,

Guangdong province 528400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Zhongshan Shijiayuan Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Zhongshan Shijiayuan Technology Co., Ltd. have?

Zhongshan Shijiayuan Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Zhongshan Shijiayuan Technology Co., Ltd. file in?

Zhongshan Shijiayuan Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Zhongshan Shijiayuan Technology Co., Ltd.'s most well-known trademarks?

Zhongshan Shijiayuan Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as STRAPHENSE. These are among 1 currently registered trademark in the portfolio.

What is Zhongshan Shijiayuan Technology Co., Ltd.'s trademark registration success rate?

Zhongshan Shijiayuan Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.